Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR‐PI3K‐AKT‐mTOR signalling pathway

This study aimed to explore the underlying mechanism of linc01014 in oesophagus cancer gefitinib resistance. Gefitinib‐resistant oesophagus squamous cell carcinoma (ESCC gefitinibR) cell lines were constructed by using different gefitinib treatment in FLO‐1, KYAE‐1, TE‐8 and TE‐5 cell lines and conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xiao, Cui, Guanghui, Liu, Shuaishuai, Zhao, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991649/
https://www.ncbi.nlm.nih.gov/pubmed/31785047
http://dx.doi.org/10.1111/jcmm.14860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991649/
https://www.ncbi.nlm.nih.gov/pubmed/31785047
http://dx.doi.org/10.1111/jcmm.14860

Ejemplares similares